Orion Portfolio Solutions LLC Sells 7,097 Shares of Enhabit, Inc. (NYSE:EHAB)

Orion Portfolio Solutions LLC lessened its position in shares of Enhabit, Inc. (NYSE:EHAB) by 5.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 114,185 shares of the company’s stock after selling 7,097 shares during the quarter. Orion Portfolio Solutions LLC owned about 0.23% of Enhabit worth $902,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. FMR LLC raised its stake in Enhabit by 138.4% in the third quarter. FMR LLC now owns 3,388 shares of the company’s stock valued at $27,000 after buying an additional 1,967 shares during the last quarter. Quarry LP raised its position in shares of Enhabit by 242.2% in the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock valued at $33,000 after purchasing an additional 2,621 shares during the last quarter. Gladius Capital Management LP raised its position in shares of Enhabit by 78.2% in the 3rd quarter. Gladius Capital Management LP now owns 6,259 shares of the company’s stock valued at $49,000 after purchasing an additional 2,747 shares during the last quarter. Stoneridge Investment Partners LLC acquired a new stake in Enhabit in the 3rd quarter worth approximately $81,000. Finally, Canada Pension Plan Investment Board purchased a new stake in Enhabit during the 2nd quarter worth approximately $93,000.

Analyst Ratings Changes

Several research firms have recently commented on EHAB. Leerink Partners reiterated a “market perform” rating and set a $8.00 price objective (down from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. Jefferies Financial Group raised Enhabit from a “hold” rating to a “buy” rating and lifted their price target for the stock from $8.25 to $9.50 in a research report on Monday, December 9th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, Enhabit presently has a consensus rating of “Hold” and an average target price of $8.75.

Insider Buying and Selling at Enhabit

In other Enhabit news, Director Jeffrey Bolton bought 4,000 shares of the company’s stock in a transaction dated Thursday, December 12th. The shares were purchased at an average cost of $8.69 per share, for a total transaction of $34,760.00. Following the transaction, the director now directly owns 98,144 shares of the company’s stock, valued at approximately $852,871.36. The trade was a 4.25 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Stuart M. Mcguigan purchased 15,000 shares of Enhabit stock in a transaction that occurred on Tuesday, December 10th. The stock was acquired at an average cost of $8.81 per share, with a total value of $132,150.00. Following the acquisition, the director now directly owns 46,810 shares in the company, valued at $412,396.10. This trade represents a 47.15 % increase in their position. The disclosure for this purchase can be found here. 1.90% of the stock is currently owned by corporate insiders.

Enhabit Price Performance

NYSE:EHAB opened at $8.52 on Monday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The company’s fifty day moving average price is $7.56 and its 200-day moving average price is $8.30. Enhabit, Inc. has a 1-year low of $6.85 and a 1-year high of $11.74. The firm has a market capitalization of $428.42 million, a P/E ratio of -3.67 and a beta of 1.89.

Enhabit (NYSE:EHAB) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.01). The company had revenue of $253.60 million for the quarter, compared to analyst estimates of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same period in the prior year, the business posted $0.03 earnings per share. As a group, equities research analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current year.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.